Egypts Gastrointestinal diseases drugs market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Gastrointestinal diseases are defined as the condition or disease that occurs within the gastrointestinal tract. Constipation, Irritable Bowel Syndrome, Colitis, Inflammatory Bowel Disease etc. are some of the common gastrointestinal disorders. Patients with gastrointestinal disorders may experience cramps and pain in the abdomen, bloating and change in bowel habits.
According to recent statistics by the World Health Organization (WHO), the annual mortality rate associated with diarrhoea is 30 deaths per 100,000 among Egyptian children under five years old. Nearly 3.9% of reported deaths are due to rotavirus infection, whereas enteric adenovirus is the second leading cause of acute diarrhoea after rotavirus. Both viruses, as extremely etiological agents for diarrhoea, constitute a major health problem in developing countries.
Market Drivers
The increasing prevalence of GI diseases, such as inflammatory bowel disease (IBD) and ulcerative colitis, is one of the key factors driving the growth of the market. Due to changing lifestyle patterns and unhealthy dietary habits, there is an increased probability of disease recurrence among patients.
Furthermore, the rising geriatric population of Egypt, which is more susceptible to such ailments, is also driving the market growth. Various technological advancements, such as the development of innovative biosimilars and cellular therapies for the treatment of the disorder, are acting as other growth-inducing factors. These biologics are administered through intravenous and subcutaneous injections and are personalized for targeted treatments.
Other factors, including rising health consciousness among the masses, extensive research and development (R&D) activities and significant improvements in the healthcare infrastructure, especially in developing economies such as Egypt, are anticipated to drive the market further.
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.